Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The closing price of Rigel Pharmaceuticals (NASDAQ: RIGL) was $16.47 for the day, down -0.18% from the previous closing price of $16.50. In other words, the price has decreased by -$0.18 from its previous closing price. On the day, 0.56 million shares were traded. RIGL stock price reached its highest trading level at $16.86 during the session, while it also had its lowest trading level at $15.62.
Ratios:
Our analysis of RIGL’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.54 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.87. For the most recent quarter (mrq), Quick Ratio is recorded 1.81 and its Current Ratio is at 1.96.
Piper Sandler Downgraded its Overweight to Neutral on June 08, 2022, whereas the target price for the stock was revised from $7 to $1.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 05 ’24 when Santos David A sold 8,918 shares for $1.14 per share. The transaction valued at 10,167 led to the insider holds 349,093 shares of the business.
Santos David A sold 5,601 shares of RIGL for $6,329 on Feb 02 ’24. The EVP, Chief Commercial Officer now owns 358,011 shares after completing the transaction at $1.13 per share. On Feb 05 ’24, another insider, Schorno Dean L, who serves as the EVP & Chief Financial Officer of the company, sold 7,027 shares for $1.14 each. As a result, the insider received 8,011 and left with 402,891 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RIGL now has a Market Capitalization of 290119040 and an Enterprise Value of 329214720. As of this moment, Rigel’s Price-to-Earnings (P/E) ratio for their current fiscal year is 76.04, and their Forward P/E ratio for the next fiscal year is 16.86. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.76. Its current Enterprise Value per Revenue stands at 2.092 whereas that against EBITDA is 29.083.
Stock Price History:
Over the past 52 weeks, RIGL has reached a high of $29.82, while it has fallen to a 52-week low of $7.48. The 50-Day Moving Average of the stock is -18.27%, while the 200-Day Moving Average is calculated to be 19.16%.
Shares Statistics:
RIGL traded an average of 232.93K shares per day over the past three months and 279910 shares per day over the past ten days. A total of 17.61M shares are outstanding, with a floating share count of 17.27M. Insiders hold about 1.98% of the company’s shares, while institutions hold 67.84% stake in the company. Shares short for RIGL as of 1734048000 were 635441 with a Short Ratio of 2.73, compared to 1731628800 on 462667. Therefore, it implies a Short% of Shares Outstanding of 635441 and a Short% of Float of 3.6799999999999997.
